Economic activity and the value of medical innovation during a pandemic
Year of publication: |
2021
|
---|---|
Authors: | Mulligan, Casey B. |
Published in: |
Journal of benefit-cost analysis : JBCA. - Cambridge : Cambridge Univ. Press, ISSN 2152-2812, ZDB-ID 2573466-0. - Vol. 12.2021, 3, p. 420-440
|
Subject: | medical innovation | national accounting | pandemic | vaccination | Coronavirus | Innovation | Epidemie | Epidemic | Medizin | Medical sciences | Arzneimittel | Pharmaceuticals | Impfung | Vaccination | Volkswirtschaftliche Gesamtrechnung | National accounts | Medizinprodukt | Medical device | Pharmakologie | Pharmacology |
-
Great expectations : social distancing in anticipation of pharmaceutical innovations
Makrēs, Miltiadēs, (2020)
-
Testing regimes in clinical trials : evidence from four polio vaccine trajectories
Yaqub, Ohid, (2017)
-
Accelerating vaccine innovation for emerging infectious diseases via parallel discovery
Barberio, Joseph, (2023)
- More ...
-
Uncertainty, redistribution, and the labor market since 2007
Mulligan, Casey B., (2014)
-
Transitional Dynamics in Two-Sector Models of Endogenous Growth
Mulligan, Casey B., (1992)
-
U.S. Money Demand: Surprising Cross-Sectional Estimates
Sala-i-Martin, Xavier, (1992)
- More ...